Recombinant glycoprotein 63 (Gp63) of Trypanosoma carassii suppresses antimicrobial responses of goldfish (Carassius auratus L.) monocytes and macrophages

International Journal for Parasitology
Ayoola Oladiran, Miodrag Belosevic

Abstract

We previously reported that proteins secreted by Trypanosoma carassii play a role in evasion of fish host immune responses. To further understand how these parasites survive in the host, we cloned and expressed T. carassii glycoprotein 63 (Tcagp63), and generated a rabbit polyclonal antibody to the recombinant protein (rTcagp63). Tcagp63 was similar to gp63 of other trypanosomes and grouped with Trypanosoma cruzi and Trypanosoma brucei gp63 in phylogenetic analysis. We showed that rTcagp63 down-regulated Aeromonas salmonicida and recombinant goldfish TNFα2-induced production of reactive oxygen and nitrogen intermediates. Macrophages treated with rTcagp63 also exhibited significant reduction in the expression of inducible nitric oxide synthase (iNOS)-A, TNFα-1 and TNFα-2. Recombinant Tcagp63 bound to and was internalised by goldfish macrophages. The Tcagp63 may act by altering the signalling events important in downstream monocyte/macrophage antimicrobial and other cytokine-induced functions. We believe that this is the first report on downregulation of antimicrobial responses by trypanosome gp63.

References

Jan 15, 1988·Molecular and Biochemical Parasitology·J A Kink, K P Chang
Jan 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·C S Chang, K P Chang
May 1, 1982·Reviews of Infectious Diseases·J J Ellner, A A Mahmoud
Jun 20, 2000·Parasitology Today·M G Rittig, C Bogdan
May 3, 2002·Molecular and Biochemical Parasitology·Chaoqun YaoMary E Wilson
Apr 23, 2003·The Journal of Biological Chemistry·Douglas J LaCountJohn E Donelson
Aug 19, 2003·Parasitology Research·Charles L Jaffe, Dennis M Dwyer
Oct 18, 2003·Molecular and Biochemical Parasitology·Chaoqun YaoMary E Wilson
Feb 22, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Devki Nandan, Neil E Reiner
Nov 12, 2005·Parasitology·D J Gregory, M Olivier
Mar 28, 2006·Molecular and Biochemical Parasitology·Amy E GruszynskiJames D Bangs
Dec 16, 2006·Parasitology Research·Palmy R JesudhasanPatrick T K Woo
Oct 24, 2007·PLoS Pathogens·Paul M GrandgenettJohn E Donelson
Oct 4, 2008·Developmental and Comparative Immunology·Leon Grayfer, Miodrag Belosevic
Nov 17, 2009·Developmental and Comparative Immunology·Ayoola Oladiran, Miodrag Belosevic
Apr 20, 2011·Parasitology Research·Lina MaJun Yu

❮ Previous
Next ❯

Citations

Jul 23, 2013·Developmental and Comparative Immunology·Patrick T K Woo, Bernadette F Ardelli
Mar 26, 2016·Molecular and Biochemical Parasitology·Andrew P Jackson

❮ Previous
Next ❯

Related Concepts

Related Feeds

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.